Want to see SNYR full AI Analyst Report?
SNYR Stock Chart & Stats
$0.17
<$0.01(1.97%)
At close: 4:00 PM EDT
$0.17
<$0.01(1.97%)
Day’s Range― - ―
52-Week Range$0.09 - $3.18
Previous CloseN/A
Volume268.77K
Average Volume (3M)136.07K
Market Cap
$1.50M
Enterprise Value$41.94
Total Cash (Recent Filing)$292.12K
Total Debt (Recent Filing)$27.75M
Price to Earnings (P/E)―
Beta1.63
Next Earnings
Nov 12, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.60
Shares Outstanding14,899,883
10 Day Avg. Volume89,526
30 Day Avg. Volume136,069
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)-0.78
Price to Sales (P/S)0.60
P/FCF Ratio-7.00
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price Target
$3.75Price Target Upside2105.88% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)-0.19
Revenue Forecast (FY)$32.00M
Bulls Say, Bears Say
Bulls Say
High Gross MarginA consistently high gross margin indicates that Synergy CHC’s products retain meaningful gross profit after direct costs. This provides a foundation for recovery if the company can restore revenue scale and control operating expenses.
Improving Free Cash Flow TrendAlthough free cash flow remains negative, the narrower loss versus 2024 suggests some improvement in cash usage. Sustaining this trend could reduce funding needs and improve the company’s ability to stabilize operations over time.
Financing And Listing FlexibilityApproved equity and capital-structure measures give management additional tools to address financing needs and potential listing requirements. These actions may support continuity, although they also carry dilution and restructuring risks.
Bears Say
Persistent Financial DistressShrinking revenue, widening losses, negative EBITDA, and recurring cash consumption indicate that the business is not currently self-funding. Without a durable earnings recovery, external capital may remain necessary to maintain operations.
Stressed Balance SheetNegative equity and debt far exceeding the asset base indicate substantial solvency risk and limited financial flexibility. This weak capital structure can constrain investment, increase reliance on lenders, and make recovery more difficult.
Major Customer LossThe loss of Costco removes a major revenue channel after a relationship lasting more than 16 years. Replacing that volume could require substantial time and spending, creating lasting pressure on revenue, liquidity, and operating scale.
Synergy CHC News
SNYR FAQ
What was Synergy CHC’s price range in the past 12 months?
Synergy CHC lowest stock price was $0.09 and its highest was $3.18 in the past 12 months.
What is Synergy CHC’s market cap?
Synergy CHC’s market cap is $1.50M.
When is Synergy CHC’s upcoming earnings report date?
Synergy CHC’s upcoming earnings report date is Nov 12, 2026 which is in 79 days.
How were Synergy CHC’s earnings last quarter?
Currently, no data Available
Is Synergy CHC overvalued?
According to Wall Street analysts Synergy CHC’s price is currently Undervalued.
Does Synergy CHC pay dividends?
Synergy CHC does not currently pay dividends.
What is Synergy CHC’s EPS estimate?
Synergy CHC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Synergy CHC have?
Synergy CHC has 14,899,883 shares outstanding.
What happened to Synergy CHC’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Synergy CHC?
Currently, no hedge funds are holding shares in SNYR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Synergy CHC
Synergy CHC Corp. operates as a distributor of diverse consumer health, beauty, and lifestyle merchandise across the United States, Canada, and the United Kingdom. The company's brand portfolio features FOCUSfactor, specializing in nutritional supplements aimed at enhancing brain function. It also offers the Flat Tummy line, which includes a range of wellness and fashion items such as specialty teas, meal replacement shakes, lollipops, dietary aids, apparel, and exercise accessories. Furthermore, under the Hand MD brand, Synergy CHC Corp. provides anti-aging skincare products, encompassing serums and creams designed for exfoliation, skin repair, and rehydration, as well as hand hygiene products like soaps and sanitizers. These goods are made available to consumers through conventional retail partners and significant television advertising campaigns. The company's skincare range, in particular, is also sold directly via online platforms. Founded in 2010, the firm was originally named Synergy Strips Corp. and rebranded to Synergy CHC Corp. in August 2015. Its primary business operations are based in Westbrook, Maine.
SNYR Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presents a mixed picture. Material one-time charges (notably a $6.66M bad debt allowance, inventory and media write-offs, and a ~$2.9M license revenue reversal) produced large GAAP losses and pushed operating expenses and adjusted EBITDA down. Offsetting these negatives, management highlighted meaningful strategic progress: beverage early traction (Q1 2026 > all of 2025), Mexico subsidiary and Costco Mexico entry, expanded Kroger distribution, stronger cash and working capital, and management’s contention that normalized gross margins are healthy. Operational risks remain (Flat Tummy weakness, TV advertising not restarted, and elevated inventory levels), but management frames many of the financial setbacks as one-time items with a path to improved normalized performance. Overall, positives and negatives are balanced.View all SNYR earnings summariesSNYR Stock 12 Month Forecast
Average Price Target
$3.75
▲(2105.88% Upside)
Technical Analysis
Ownership Overview
34.42% Insiders
4.54% Mutual Funds
1.19% Other Institutional Investors
59.59% Public Companies and
Individual Investors